Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 3/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.46 |
| ▸ | BCR | P11274 | 3/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.42 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.42 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4395181 | 0.89 | CA1 (0.54) | CA1CA2GABRA1GABRB2HSP90AA1 | |
| SCHEMBL29392149 | 0.86 | ALOX5 (0.56) | CA1CA2ABL1ABCB1BCR | |
| SCHEMBL503448 | 0.86 | ALOX5 (0.56) | CA1CA2ABL1ABCB1BCR | |
| SCHEMBL7080561 | 0.84 | LMNA (0.53) | CA1CA2ABL1ABCB1BCR | |
| SCHEMBL16581399 | 0.82 | APP (0.56) | CA1CA2ABL1ABCB1BCR | |
| SCHEMBL30017397 | 0.81 | ALOX5 (0.53) | CA1CA2ABL1ABCB1BCR | |
| SCHEMBL8714891 | 0.80 | ALOX5 (0.57) | CA1CA2GABRA1GABRB2HSP90AA1 | |
| SCHEMBL20056400 | 0.80 | LMNA (0.46) | CA1CA2GABRA1GABRB2HSP90AA1 | |
| SCHEMBL30017156 | 0.77 | ALOX5 (0.63) | CA1CA2GABRA1GABRB2NPC1 | |
| SCHEMBL29457584 | 0.76 | GABRA1 (0.52) | CA1CA2GABRA1GABRB2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030139479-A1 | Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same | WARNER-LAMBERT COMPANY | 2003-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030139479-A1 | Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same | AS3MT, PTPN1, NONO | CA1 4247/4885CA2 3114/4885ABL1 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.